Home Newsfeeds JMP Securities Downgrades Minerva Neurosciences to Market Perform

JMP Securities Downgrades Minerva Neurosciences to Market Perform

JMP Securities analyst Jason Butler downgrades Minerva Neurosciences (NASDAQ:NERV) from Market Outperform to Market Perform.

byBenzinga Newsdesk

October 17, 2022

1 minute read

JMP Securities analyst Jason Butler downgrades Minerva Neurosciences (NASDAQ:NERV) from Market Outperform to Market Perform.

Analyst Ratings

Demystifying Plexus: Insights From 4 Analyst Reviews

By Benzinga Insights

January 18, 3:00 PM

In the last three months, 4 analysts have published ratings on Plexus (NASDAQ:PLXS), offering a diverse range of…

PLXS

Texas Instruments Q1 Earnings: EPS Beat, Revenue Beat Despite Decline Across All End Markets

By Adam Eckert

April 23, 4:29 PM

Texas Instruments reported first-quarter revenue of $3.66 billion, which beat the consensus estimate of $3.611 billion, according to Benzinga Pro. The company's top-line results were down 16% on a year-over-year basis and down 10% sequentially as revenue declined across all end markets.

TXN

Barclays Maintains Equal-Weight on ICL Group, Lowers Price Target to $11

By Benzinga Newsdesk

November 17, 8:07 AM

Barclays analyst Benjamin Theurer maintains ICL Group (NYSE:ICL) with a Equal-Weight and lowers the price target from $12 to $11.

ICL

Kandi Technologies Announces CEO Transition; Mr. Xiaoming Hu Hands Ceo Role To Dr. Xueqin Dong; Mr. Hu Remains Board Chair And Large Shareholder

By Benzinga Newsdesk

January 11, 5:28 PM

Kandi Technologies Group, Inc. (the "Company," "we" or "Kandi") (NASDAQ GS: KNDI), today announced the appointment of Dr. Xueqin Dong as Chief Executive Officer, effective January 10, 2023.

KNDI

JMP Securities Downgrades Minerva Neurosciences to Market Perform

Related Posts

Demystifying Plexus: Insights From 4 Analyst Reviews

Texas Instruments Q1 Earnings: EPS Beat, Revenue Beat Despite Decline Across All End Markets

Barclays Maintains Equal-Weight on ICL Group, Lowers Price Target to $11

Kandi Technologies Announces CEO Transition; Mr. Xiaoming Hu Hands Ceo Role To Dr. Xueqin Dong; Mr. Hu Remains Board Chair And Large Shareholder